A new ISO edition is coming, and for many companies that immediately triggers a familiar type of panic: a new standard arrives, the old one gets replaced, and suddenly it feels like the whole QMS needs to be reviewed, procedures rewritten, everyone retrained, audits reopened, and the organization made to suffer in a controlled manner.
Fortunately, at least in this case, I do not see much reason for drama.
ISO 9001:2026 has not been published yet.
For now, it exists as a draft, with publication expected in September 2026.From a medical software perspective, this does not currently look like the kind of revision that should, by itself, trigger a redesign of your SDLC.
Medical software is still governed primarily by more specific frameworks: ISO 13485, IEC 62304, and then MDR / IVDR in Europe or FDA requirements in the US.
FDA’s Quality Management System Regulation also took effect on February 2, 2026, which is a much more immediate compliance anchor for U.S.-facing medical device software organizations.
That is where the real regulatory and process weight still sits.
If a company follows both ISO 9001 and ISO 13485, then yes, the final 2026 edition may still influence some surrounding processes, such as:
training,
audits,
supplier management,
CAPA,
management review inputs,
or the way organizational context is described.
But that is not the same as a fundamental rewrite of medical software development rules.
One point worth noting is that climate-related thinking is already here, even before ISO 9001:2026 arrives.
The 2024 amendment to ISO 9001:2015 already requires organizations to determine whether climate change is a relevant issue.
For a medical software company, that may sound abstract, but in practice it can affect rather concrete things: cloud hosting resilience, data-center dependency, supplier continuity, disaster recovery, business continuity, and service availability where those matter for product quality or support.
So my practical conclusion today would be:
no need to redesign your SDLC because of ISO 9001:2026 alone,
do keep your QMS flexible enough to absorb terminology and framing changes later,
keep the main compliance focus on ISO 13485 alignment, IEC 62304 lifecycle evidence, MDR / IVDR software qualification, and FDA QMSR alignment.
And honestly, one thing is a bit disappointing here.
If we are revising ISO 9001 after roughly a decade, one could expect stronger treatment of what actually changed in the world during that time: AI, cybersecurity, sustainability, and digital dependency.
So far, apart from climate-related context, this does not look especially ambitious in those areas. ISO’s own update on the revision focuses on the drafting process and timeline, not on any sweeping new obligations related to those topics.
So for medical software companies, the message is rather simple:
Do not ignore it.
Do not panic.And definitely do not treat it as the standard that suddenly redefines medical software compliance.What do you think - is ISO 9001 still strategically useful in medtech software organizations, or is it mostly a supporting layer around the standards that actually drive the work?
We'll address every query and pinpoint the ideal strategy for your project's success.
Fill out the form, and we’ll get back to you shortly.
Chief Executive Officer